Why this small cap biotech has rocketed 2,511% in the last 5 months

The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today, taking 5-month returns to a phenomenal 2,585%.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today. Zoono has seen very strong share price growth since last September, and particularly since the outbreak of the coronavirus.

The Zoono share price was sitting at just $0.072 in September last year and has since shot all the way up to $1.88 at the time of writing – a phenomenal 2,511% increase.

Zoono is a global biotech company that is involved in the development, manufacture and global distribution of a unique range of long-lasting and environmentally friendly antimicrobial solutions. The company currently has a market capitalization of $307 million.

Following the coronavirus outbreak, Zoono commented that there has been a high interest in Zoono's technology given its proven efficacy against viruses and bacteria, and ability to prevent cross-contamination.

Recently, Zoono reported unaudited revenues for the quarter so far to 10 February 2020 of NZ$2.4 million, with on-line sales in Australia and New Zealand contributing strongly.

a woman

Announcement in response to coronavirus

On 30 January 2020, Zoono announced to the market its confidence of being well-positioned to be part of the solution to both coronavirus and other new virus threats. The company believes that its Zoono technology, particularly its longevity and killing methodology, delivers an ideal solution.

At this time, the company stated that Zoono's Z71 Microbe Shield Surface Sanitiser was successfully tested in 2014 against bovine coronavirus (a surrogate recognised by the World Health Organisation for other members of the coronaviridae family, including the MERS virus). Test results confirmed a 99.99% efficacy in five minutes.

Zoono's Z71 Microbe Shield Surface Sanitiser and GermFree24 Hand Sanitiser products were recently sent to a German laboratory for testing against the latest Chinese strain of the coronavirus (2019-nCoV).

Operationally, once the impact of the new coronavirus emerged, Zoono made an immediate decision in early January to ramp up production of its key active ingredients and its Z71 Microbe Shield Surface Sanitiser and GermFree24 Hand Sanitiser finished goods.

Recent agreement for Chinese childcare & hotel sectors

A week ago, on February 10, Zoono announced it had entered into an exclusive distribution agreement with Beijing Youmeng Technology and Development Limited for the childcare and hotel sectors in China.

At this time, Zoono had received an initial payment of NZD$775,000 from Beijing Youmeng Technology and Development Limited.

Zoono commented that this agreement in the childcare and hotel sectors in China is another step in Zoono's strategy to focus on specific sectors and on the appointment of reputable distributors with explicit expertise in these market segments.

Zoono also pointed out that it has sought to exercise greater control over the activities and performance of its distributors in its new distribution arrangements.

This agreement is the fourth distribution agreement entered into by the company for an industry sector in the Chinese market in the last six months.

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Share Market News

5 things to watch on the ASX 200 on Monday

It looks set to be a tough start to the week for Aussie investors.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Broker Notes

2 ASX shares Morgans thinks are worth gobbling up right now

The broker sees big upside for these stocks.

Read more »

A man wearing glasses sits back in his desk chair with his hands behind his head staring smiling at his computer screens as the ASX share prices keep rising
Broker Notes

Bell Potter says these ASX 200 stocks could rise 50%+

The broker has good things to say about these stocks.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

fire man running on lava
Share Market News

ASX 200 energy shares lead the market for a third week

Energy shares have risen 16.21% while the ASX 200 has lost 8.37% since the war in Iran began.

Read more »

Two happy and excited friends in euphoria holding a smartphone, after winning in a bet.
Share Market News

These ASX 200 shares could rise 40% to 60%

Morgans thinks these shares could deliver big returns over the next 12 months.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Opinions

Why buying ASX shares in March could supercharge your wealth

I think there are opportunities galore right now.

Read more »

A woman gives two fist pumps with a big smile as she learns of her windfall, sitting at her desk.
Share Market News

Why these Vanguard ETFs could be best buys in 2026

From global markets to emerging Asia, these Vanguard ETFs provide diversified exposure for investors in 2026.

Read more »